Clean Science and Technology Announces Q4 FY26 Earnings Call for May 14

Consolidated revenue was ₹219 crore in Q3 FY26, down 9% year-on-year. Standalone revenue fell 20% YoY to ₹185 Cr in Q3 FY2026, with PAT declining 29.7% to ₹52 Cr.
Reader Takeaway: Earnings call to clarify margin pressures and growth outlook amid recent revenue declines.

What just happened (today’s filing)

Clean Science and Technology Ltd has announced its much-anticipated earnings conference call. The call is scheduled for Thursday, May 14, 2026, commencing at 4:00 PM Indian Standard Time.

The primary agenda of this conference call is to discuss the company's audited financial results for the fourth quarter and the entire financial year ended March 31, 2026.

Why this matters

Earnings conference calls provide investors and analysts with a direct channel to understand a company's financial performance, strategic decisions, and future outlook from management.

This event is crucial for Clean Science as it follows a period of challenging financial results and analyst downgrades, making management commentary highly anticipated.

The backstory (grounded)

Clean Science and Technology Limited is a prominent Indian specialty chemical manufacturer known for its sustainable and eco-friendly production processes. The company operates across key segments including Performance Chemicals, Pharmaceutical Intermediates, FMCG Chemicals, and Agrochemical Intermediates.

However, recent financial performance has shown headwinds. In Q3 FY26, the company reported consolidated revenue of ₹219 crore, a 9% year-on-year decrease, with standalone revenue falling 20% YoY to ₹185 Cr and PAT declining 29.7% to ₹52 Cr due to margin compression. Analysts have also downgraded earnings per share forecasts, with revenue predictions for 2027 revised downwards, and the company was downgraded to 'Sell' by MarketsMOJO in March 2024 citing negative financials and underperformance. The company also lost a key customer and faced US tariff impacts, affecting its cosmetics segment.

What changes now

• Investors will gain direct insights into the detailed financial performance for Q4 FY26 and the full FY26.
• Management commentary will shed light on the reasons behind recent revenue and margin pressures.
• The call offers an opportunity to understand the company's strategy to navigate challenges such as competition, tariffs, and customer loss.
• Future guidance on growth drivers, capex plans, and market outlook will be key takeaways for investors.

Risks to watch

• Analysts have significantly downgraded EPS forecasts, indicating potential future earnings shortfalls.
• The company faced a downgrade to 'Sell' by MarketsMOJO due to negative financial results and valuation concerns.
• Loss of a key cosmetics customer and US tariff impacts have already affected revenue streams.
• Continued pricing pressure from Chinese competitors in key segments like performance chemicals remains a concern.

Peer comparison

Clean Science competes with established players in the specialty chemicals sector such as Vinati Organics Ltd., Privi Speciality Chemicals Ltd., Galaxy Surfactants Ltd., and Jubilant Ingrevia Ltd. While peers like Vinati Organics reported a 3.6% YoY revenue increase in Q3 FY25, and Galaxy Surfactants saw a 3.4% YoY revenue rise, Clean Science has faced recent revenue contractions. The call will be key to understanding how Clean Science plans to regain competitive footing against these peers.

Context metrics (time-bound)

• In Q3 FY2026, Clean Science & Technology's consolidated revenue was ₹219 crore, reflecting a 9% year-on-year decline.
• Standalone Profit After Tax (PAT) for Q3 FY2026 was ₹46 crore, a 30.3% decrease year-on-year.
• Standalone revenue for Q3 FY2026 stood at ₹185 crore, marking a 20% year-on-year contraction.

What to track next

• Listen to the earnings conference call on May 14, 2026, for detailed financial discussions and management insights.
• Analyze the specific drivers and pressures revealed for Q4 FY26 and the full year.
• Monitor management's commentary on the impact of Chinese competition and US tariffs.
• Evaluate any revised outlook or guidance provided for the upcoming fiscal periods.
• Track the company's progress on new capacity expansions and their expected revenue contribution.
• Observe how the company plans to address the recent customer loss and its impact on FMCG segment performance.